Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [18F]flortaucipir study

被引:6
作者
O'Connor, Antoinette [1 ,2 ]
Cash, David M. [1 ]
Poole, Teresa [1 ,3 ]
Markiewicz, Pawel J. [4 ]
Fraser, Maggie R. [1 ]
Malone, Ian B. [1 ]
Jiao, Jieqing [4 ]
Weston, Philip S. J. [1 ]
Flores, Shaney [5 ]
Hornbeck, Russ [5 ]
McDade, Eric [6 ]
Schoell, Michael [1 ,7 ]
Gordon, Brian A. [5 ]
Bateman, Randall J. [6 ]
Benzinger, Tammie L. S. [5 ]
Fox, Nick C. [1 ,2 ]
机构
[1] UCL Queen Sq Inst Neurol, Dementia Res Ctr, London, England
[2] UK Dementia Res Inst UCL, London, England
[3] London Sch Hyg & Trop Med, Dept Med Stat, London, England
[4] UCL, Ctr Med Image Comp Med Phys & Biomed Engn, London, England
[5] Washington Univ St Louis, Dept Radiol, St Louis, MO USA
[6] Washington Univ St Louis, Dept Neurol, St Louis, MO USA
[7] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden
基金
美国国家卫生研究院; 加拿大健康研究院; 英国医学研究理事会;
关键词
POSITRON-EMISSION-TOMOGRAPHY; PET PATTERNS; F-18-AV-1451; DEPOSITION; PHENOTYPE; TAUOPATHY; TRACER; BRAIN; ONSET;
D O I
10.1186/s13195-023-01234-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cortical tau accumulation is a key pathological event that partly defines Alzheimer's disease (AD) onset and is associated with cognitive decline and future disease progression. However, an improved understanding of the timing and pattern of early tau deposition in AD and how this may be tracked in vivo is needed. Data from 59 participants involved in two longitudinal cohort studies of autosomal dominant AD (ADAD) were used to investigate whether tau PET can detect and track presymptomatic change; seven participants were symptomatic, and 52 were asymptomatic but at a 50% risk of carrying a pathogenic mutation. All had baseline flortaucipir (FTP) PET, MRI and clinical assessments; 26 individuals had more than one FTP PET scan. Standardised uptake value ratios (SUVRs) in prespecified regions of interest (ROIs) were obtained using inferior cerebellar grey matter as the reference region. We compared the changes in FTP SUVRs between presymptomatic carriers, symptomatic carriers and non-carriers, adjusting for age, sex and study site. We also investigated the relationship between regional FTP SUVRs and estimated years to/from symptom onset (EYO). Compared to both non-carriers and presymptomatic carriers, FTP SUVRs were significantly higher in symptomatic carriers in all ROIs tested (p < 0.001). There were no significant regional differences between presymptomatic carriers and non-carriers in FTP SUVRs, or their rates of change (p > 0.05), although increased FTP signal uptake was seen posteriorly in some individuals around the time of expected symptom onset. When we examined the relationship of FTP SUVR with respect to EYO, the earliest significant regional difference between mutation carriers and non-carriers was detected within the precuneus prior to estimated symptom onset in some cases. This study supports preliminary studies suggesting that presymptomatic tau tracer uptake is rare in ADAD. In cases where early uptake was seen, there was often a predilection for posterior regions (the precuneus and post-cingulate) as opposed to the medial temporal lobe, highlighting the importance of examining in vivo tau uptake beyond the confines of traditional Braak staging.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Longitudinal tau accumulation and atrophy in aging and alzheimer disease
    Harrison, Theresa M.
    La Joie, Renaud
    Maass, Anne
    Baker, Suzanne L.
    Swinnerton, Kaitlin
    Fenton, Laura
    Mellinger, Taylor J.
    Edwards, Lauren
    Pham, Julie
    Miller, Bruce L.
    Rabinovici, Gil D.
    Jagust, William J.
    ANNALS OF NEUROLOGY, 2019, 85 (02) : 229 - 240
  • [22] A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis
    Leuzy, Antoine
    Pascoal, Tharick A.
    Strandberg, Olof
    Insel, Philip
    Smith, Ruben
    Mattsson-Carlgren, Niklas
    Benedet, Andrea L.
    Cho, Hannah
    Lyoo, Chul H.
    La Joie, Renaud
    Rabinovici, Gil D.
    Ossenkoppele, Rik
    Rosa-Neto, Pedro
    Hansson, Oskar
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (07) : 2295 - 2305
  • [23] Performance of a [18F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies
    Coomans, Emma M.
    de Koning, Lotte A.
    Rikken, Roos M.
    Verfaillie, Sander C. J.
    Visser, Denise
    den Braber, Anouk
    Tomassen, Jori
    van de Beek, Marleen
    Collij, Lyduine E.
    Lemstra, Afina W.
    Windhorst, Albert D.
    Barkhof, Frederik
    Golla, Sandeep S. V.
    Visser, Pieter Jelle
    Scheltens, Philip
    van der Flier, Wiesje M.
    Ossenkoppele, Rik
    van Berckel, Bart N. M.
    van de Giessen, Elsmarieke
    NEUROLOGY, 2023, 101 (19) : E1850 - E1862
  • [24] Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351
    Lockhart, Samuel N.
    Baker, Suzanne L.
    Okamura, Nobuyuki
    Furukawa, Katsutoshi
    Ishiki, Aiko
    Furumoto, Shozo
    Tashiro, Manabu
    Yanai, Kazuhiko
    Arai, Hiroyuki
    Kudo, Yukitsuka
    Harada, Ryuichi
    Tomita, Naoki
    Hiraoka, Kotaro
    Watanuki, Shoichi
    Jagust, William J.
    PLOS ONE, 2016, 11 (06):
  • [25] [18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease
    Bohorquez, Sandra Sanabria
    Marik, Jan
    Ogasawara, Annie
    Tinianow, Jeff N.
    Gill, Herman S.
    Barret, Olivier
    Tamagnan, Gilles
    Alagille, David
    Ayalon, Gai
    Manser, Paul
    Bengtsson, Thomas
    Ward, Michael
    Williams, Simon-Peter
    Kerchner, Geoffrey A.
    Seibyl, John P.
    Marek, Kenneth
    Weimer, Robby M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (10) : 2077 - 2089
  • [26] 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases
    Soleimani-Meigooni, David N.
    Iaccarino, Leonardo
    La Joie, Renaud
    Baker, Suzanne
    Bourakova, Viktoriya
    Boxer, Adam L.
    Edwards, Lauren
    Eser, Rana
    Gorno-Tempini, Maria-Luisa
    Jagust, William J.
    Janabi, Mustafa
    Kramer, Joel H.
    Lesman-Segev, Orit H.
    Mellinger, Taylor
    Miller, Bruce L.
    Pham, Julie
    Rosen, Howard J.
    Spina, Salvatore
    Seeley, William W.
    Strom, Amelia
    Grinberg, Lea T.
    Rabinovici, Gil D.
    BRAIN, 2020, 143 : 3477 - 3494
  • [27] Cholinergic Changes in Aging and Alzheimer Disease: An [18F]-F-A-85380 Exploratory PET Study
    Lagarde, Julien
    Sarazin, Marie
    Chauvire, Valerie
    Stankoff, Bruno
    Kas, Aurelie
    Lacomblez, Lucette
    Peyronneau, Marie-Anne
    Bottlaender, Michel
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2017, 31 (01) : 8 - 12
  • [28] Rates of longitudinal change in 18F-flortaucipir PET vary by brain region, cognitive impairment, and age in atypical Alzheimer's disease
    Phillips, Jeffrey S.
    Nitchie, Frederick J.
    Da Re, Fulvio
    Olm, Christopher A.
    Cook, Philip A.
    McMillan, Corey T.
    Irwin, David J.
    Gee, James C.
    Dubroff, Jacob G.
    Grossman, Murray
    Nasrallah, Ilya M.
    ALZHEIMERS & DEMENTIA, 2022, 18 (06) : 1235 - 1247
  • [29] [18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease
    Okamura, N
    Arai, H
    Higuchi, M
    Tashiro, M
    Matsui, T
    Hu, XS
    Takeda, A
    Itoh, M
    Sasaki, H
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2001, 25 (02) : 447 - 456
  • [30] A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson’s disease
    Catherine L. Gallagher
    Sterling C. Johnson
    Barbara B. Bendlin
    Moo K. Chung
    James E. Holden
    Terrence R. Oakes
    Benjamin R. Brooks
    Richard A. Konopacki
    Selami Dogan
    James H. Abbs
    Guofan Xu
    Robert J. Nickles
    Robert W. Pyzalski
    Onofre T. DeJesus
    W. Douglas Brown
    Brain Imaging and Behavior, 2011, 5 : 203 - 211